Abstract
The paradigmatic feature of long-term memory (LTM) is its persistence. However, little is known about the mechanisms that make some LTMs last longer than others. In rats, a long-lasting fear LTM vanished rapidly when the D1 dopamine receptor antagonist SCH23390 was injected into the dorsal hippocampus 12 hours, but not immediately or 9 hours, after the fearful experience. Conversely, intrahippocampal application of the D1 agonist SK38393 at the same critical post-training time converted a rapidly decaying fear LTM into a persistent one. This effect was mediated by brain-derived neurotrophic factor and regulated by the ventral tegmental area (VTA). Thus, the persistence of LTM depends on activation of VTA/hippocampus dopaminergic connections and can be specifically modulated by manipulating this system at definite post-learning time points.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
-
8-Bromo Cyclic Adenosine Monophosphate / pharmacology
-
Animals
-
Benzazepines / pharmacology
-
Brain-Derived Neurotrophic Factor / metabolism
-
Dopamine / physiology*
-
Dopamine Agonists / pharmacology
-
Dopamine Antagonists / pharmacology
-
Fear
-
Hippocampus / drug effects
-
Hippocampus / physiology*
-
Male
-
Memory / drug effects
-
Memory / physiology*
-
Phosphorylation
-
Rats
-
Rats, Wistar
-
Receptors, Dopamine D1 / agonists
-
Receptors, Dopamine D1 / antagonists & inhibitors
-
Receptors, Dopamine D1 / metabolism
-
Receptors, N-Methyl-D-Aspartate / metabolism
-
Time Factors
-
Tyrosine 3-Monooxygenase
-
Ventral Tegmental Area / physiology*
Substances
-
Benzazepines
-
Brain-Derived Neurotrophic Factor
-
Dopamine Agonists
-
Dopamine Antagonists
-
Receptors, Dopamine D1
-
Receptors, N-Methyl-D-Aspartate
-
SCH 23390
-
8-Bromo Cyclic Adenosine Monophosphate
-
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
-
Tyrosine 3-Monooxygenase
-
Dopamine